Fingerprint
Dive into the research topics of 'The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin
Marcus M. Schittenhelm, Kerstin M. Kampa, Kevin W.H. Yee, Michael C. Heinrich
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations